Condition | Cell type/Species | Key findings | Proposed mediator | Implications | References | |
---|---|---|---|---|---|---|
Embryogenesis | MTZ | Zebrafish oocyte | IMP3 ↓ leads to abnormal cytoskeleton organization and cell division | Maternal mRNAs | IMP3 depletion leads to severe developmental defects | [45] |
Zebrafish oocyte | IMP3 ↑ inhibits maternal-to-zygotic transition | Maternal mRNAs | Leads to developmental delay | [46] | ||
ZGA | Mice | IMP2 ↓causes early embryonic developmental arrest | Ccar1, Rps14, IGF2 | Abundant IMP2 is essential for the embryo development | [38] | |
Implantation | Human/Bovine | Methylation ratio of IMP2↓and IMP3 ↑in receptive endometrium | No data | Predicts the estrous phase | ||
Placentation | Human | IMP1 and IMP3 ↑ | Corresponding receptors | Early dialogue between blastocysts and maternal endometrial cells | [16] | |
Ovine | IMP1-3↓ | LIN28, let-7 | Increases the degree of elongation of the conceptus abnormal m6A modification | [64] | ||
PA | Mice | The expression of IMP1 and IMP2 is perturbed | No data | during early development in PA embryos | [65] | |
Mice | IMP1↓ | miR-670 | Regulates RNA methylation in PA mouse embryonic development | [66] | ||
Oocyte maturation | Â | Zebrafish oocyte | IMP3 retards the progression of oocyte maturation | Cyclin B1 | Represses oocyte maturation | [71] |
PCOS |  | Human | IMP2↓in cumulus cells from PCOS patients | No data | Predictive biomarker | [69] |
 | Human | IMP2↑in GCs and ovary | CCND2, SERBP1 | Provides new insights into the dysfunction of GCs in PCOS | [18] | |
PE | Â | HTR-8/Svneo cells | IMP1 inhibits apoptosis in HTR-8/Svneo cells | miR-423-5p | A new light on the pathogenesis of severe pre-eclampsia | [21] |
 | HTR-8/Svneo cells | IMP2 promotes the invasion and migration of HTR-8/Svneo cell | miR-181a-5p | The roles and molecular mechanisms of IMP2 in PE | [20] | |
 | Human placenta | IMP3 ↓in the placentas from PE patients | IGF2, CD44 | Predictive biomarker | [19] | |
GDM | Â | Human | Rs4402960 (IMP2) | No data | Associated with a higher risk of GDM | |
Gynecological oncology | ULM/ULMS | Human | IMP2/IMP3 | No data | Predictive marker/independent prognostic factor | |
Cervical carcinoma | SiHa cells | IMP3 ↑ facilitate cell aerobic glycolysis | Hexokinase 2 | A potential approach for cervical cancer therapeutics | [109] | |
Choriocarcinoma | JAR cells | IMP1 ↑ promotes cell migration and invasion | RSK2, PPME2 | Aggravating the choriocarcinoma disease progression | [52] | |
Endometrial carcinoma | Human | IMP3 ↑, PR, L1CAM | No data | Histological subtyping in high-grade EECs | [112] | |
Ovarian carcinoma | Human | IMP1, IMP2, IMP3 and E-cadherin | No data | Predicts disease recurrence and survival |